(Allergan plc)

	AGN latest price $223.3486 (-0.31%) ($222.4317 - $227.6146) on Wed. Oct. 22, 2014.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.58% (three month average)
RSI	47
Latest Price	$223.3486(-0.31%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 1.3% a day on average for past five trading days.
Weekly Trend	AGN declines -3.2% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(56%)    XBI(47%)    SPY(44%)    QQQ(42%)    VT(42%)
Factors Impacting AGN price	AGN will decline at least -0.79% in a week (0% probabilities).   VIXM(-32%)    TLT(-19%)    SHY(-8%)    IGOV(-6%)    GLD(-5%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.79% (StdDev 1.58%)
Hourly BBV	0 ()
Intraday Trend	-0.3%

1 - 5 Day Possible Target	$212.69(-4.77%)
Resistance Level	$226.75
5 Day Moving Average	$219.48(1.76%)
10 Day Moving Average	$219.76(1.63%)
20 Day Moving Average	$226.75(-1.5%)
To recent high	-6.7%
To recent low	14.2%
Market Cap	$73.638b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed